By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.

Contact Information

Website: www.kronosbio.com
Email: stephanie.yao@kronosbio.com
Main Phone: +1 650 781-5200
Address: 1300 So. El Camino Real
Address 2: Suite 300
State: CA
City / Town: San Mateo
Country: US
Postal Code: 94402

Issuer Information

Exchange: NGS
CEO: Norbert W. Bischofberger
Employees: 63
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A